No Data
China Reform Health Management and Services Group: 2024 Interim Performance Forecast
China Reform Health Management and Services Group (000503.SZ): Expected to lose about RMB 75.82 million in the first half of the year.
On July 9th, Gelunhui reported that the net income attributable to shareholders of the listed company for the first half of 2024 is a loss of about 75.82 million yuan, compared to a loss of 84.95 million yuan in the same period last year; the net income after deducting non-recurring gains and losses is a loss of about 81.4 million yuan, compared to a loss of 90.69 million yuan in the same period last year; the basic earnings per share was a loss of about 0.0774 yuan/share. The overall business of the company presents a seasonal feature of low in the front and high in the back. During the reporting period, the company firmly focused on the strategic plan of "three medical collaborations, innovation-driven, and digital ecology", on the one hand, it focused on improving the digital medical insurance plate.
Zhitong A Share Sale Restriction and Release List | June 13
On June 13th, a total of 8 listed companies had their restricted stocks lifted, with a total market value of about 3.163 billion yuan. The specific situation of restricted stock lifting today is as follows: stock abbreviation, stock code, type of restricted stock, number of lifted shares: China Reform Health Management and Services Group (000503), A-share issued by additional public offering for corporate allocation, 56.2893 million shares; Gansu Energy Chemical (000552), A-share issued by additional public offering for corporate allocation, 741 million shares; Aluminum Corporation of China (601600), stock-based incentive restricted circulation, 43.7442 million; Sanxiang Advanced Materials (603663), stock-based incentive restricted circulation, 535,100 shares; Rontec Co., Ltd. (605133), stock-based incentive restricted circulation, 624,900 shares.
China Reform Health Management and Services Group (stock code 000503.SZ): 56.2893 million restricted shares will be listed for circulation on June 13, accounting for 5.72% of the total share capital.
China Reform Health Management and Services Group (000503.SZ) announced that the company will lift restrictions on 56.2893 million shares, representing 5.72% of the total share capital. The unrestricted shares will be listed and traded on June 13, 2024.
Is China Reform Health Management and Services Group (SZSE:000503) A Risky Investment?
Guoxin Health (000503.SZ): Net loss of 40.3818 million yuan in the first quarter
Gelonghui, April 26 | Guoxin Health (000503.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 479.155 million yuan, down 14.08% year on year; net profit attributable to shareholders of listed companies - 40,3818 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 405.24,900 yuan; basic earnings per share - 0.0412 yuan.
No Data
